News - Page 77 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America

Post published:November 29, 2022
Post category:Press Release

Read more about the article Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue

Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue

Post published:November 29, 2022
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain in a Rodent Model with Psilocybin and Intravenous Psilocybin Alters Brain Network Dynamics in Rats at the 2022 Society for Neuroscience Conference

Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain in a Rodent Model with Psilocybin and Intravenous Psilocybin Alters Brain Network Dynamics in Rats at the 2022 Society for Neuroscience Conference

Post published:November 29, 2022
Post category:Press Release

Read more about the article atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer

atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil V. Kirpekar as Chief Business Officer

Post published:November 29, 2022
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference

COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference

Post published:November 28, 2022
Post category:Press Release

Read more about the article Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022

Post published:November 23, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing for atai’s PCN-101 Results; Tactogen Launches Community Funding Round

Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing for atai’s PCN-101 Results; Tactogen Launches Community Funding Round

Post published:November 19, 2022
Post category:Psychedelic Bulletin

Read more about the article MIND CURE ENTERS INTO BINDING LETTER OF INTENT WITH LNG ENERGY GROUP

MIND CURE ENTERS INTO BINDING LETTER OF INTENT WITH LNG ENERGY GROUP

Post published:November 18, 2022
Post category:Press Release

Read more about the article MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

Post published:November 17, 2022
Post category:News Press Release

Read more about the article Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai’s PCN-101 Phase 2a Readout

Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai’s PCN-101 Phase 2a Readout

Post published:November 17, 2022
Post category:Analysis

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.